D441 Pharmacology Final Exam Practice 2026 |WGU
1. Which term describes the process by which a drug’s concentration is
significantly reduced before it reaches systemic circulation, typically occurring in
the liver?
A. Bioavailability
B. Distribution
C. Excretion
D. First-pass effect
Answer: D
Rationale: The first-pass effect occurs when a drug is metabolized by the liver before it
reaches the systemic circulation, often significantly reducing the amount of active drug
available.
2. A patient with a low albumin level is at risk for drug toxicity when taking
drugs that are highly protein-bound. Why?
A. The drug is excreted too quickly
B. More free drug is available in the bloodstream
C. The drug cannot cross the blood-brain barrier
D. The liver metabolizes the drug too fast
Answer: B
Rationale: Albumin is a primary binding protein. Low levels mean fewer binding sites,
resulting in higher concentrations of free (active) drug, which increases the risk of toxicity.
,3. What is the primary goal of administering a loading dose of a medication?
A. To prevent side effects
B. To ensure the drug is metabolized quickly
C. To reach a therapeutic level (steady state) more rapidly
D. To bypass the first-pass effect
Answer: C
Rationale: A loading dose is a large initial dose given to achieve a therapeutic
concentration in the plasma more quickly than a maintenance dose would.
4. Which pharmacokinetic phase is most affected by a patient’s renal function?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: D
Rationale: The kidneys are the primary organs for excretion. Impaired renal function leads
to decreased clearance and potential drug accumulation.
5. A drug that binds to a receptor and activates it to produce a biological
response is known as:
A. An antagonist
B. A placebo
C. An inhibitor
D. An agonist
Answer: D
Rationale: An agonist is a molecule that mimics the action of a naturally occurring
substance by binding to and activating a receptor.
, 6. What does the term ‘therapeutic index’ (TI) represent?
A. The time it takes for a drug to reach peak effect
B. The ratio between a drug’s effective dose and toxic dose
C. The speed at which a drug is absorbed into the blood
D. The duration of a drug’s action
Answer: B
Rationale: The therapeutic index is a measure of drug safety; a narrow TI means the
difference between a therapeutic dose and a toxic dose is small.
7. Which route of administration provides 100% bioavailability?
A. Oral (PO)
B. Intravenous (IV)
C. Sublingual (SL)
D. Subcutaneous (SQ)
Answer: B
Rationale: Intravenous administration injects the drug directly into the systemic
circulation, bypassing absorption barriers and the first-pass effect.
8. What is the half-life of a drug?
A. The time required for the drug to be completely eliminated
B. The time it takes for the concentration of the drug to decrease by 50%
C. The time until the drug starts working
D. The interval between two doses
Answer: B
Rationale: Half-life is the time required for the amount of drug in the body or plasma
concentration to decrease by one-half.
1. Which term describes the process by which a drug’s concentration is
significantly reduced before it reaches systemic circulation, typically occurring in
the liver?
A. Bioavailability
B. Distribution
C. Excretion
D. First-pass effect
Answer: D
Rationale: The first-pass effect occurs when a drug is metabolized by the liver before it
reaches the systemic circulation, often significantly reducing the amount of active drug
available.
2. A patient with a low albumin level is at risk for drug toxicity when taking
drugs that are highly protein-bound. Why?
A. The drug is excreted too quickly
B. More free drug is available in the bloodstream
C. The drug cannot cross the blood-brain barrier
D. The liver metabolizes the drug too fast
Answer: B
Rationale: Albumin is a primary binding protein. Low levels mean fewer binding sites,
resulting in higher concentrations of free (active) drug, which increases the risk of toxicity.
,3. What is the primary goal of administering a loading dose of a medication?
A. To prevent side effects
B. To ensure the drug is metabolized quickly
C. To reach a therapeutic level (steady state) more rapidly
D. To bypass the first-pass effect
Answer: C
Rationale: A loading dose is a large initial dose given to achieve a therapeutic
concentration in the plasma more quickly than a maintenance dose would.
4. Which pharmacokinetic phase is most affected by a patient’s renal function?
A. Absorption
B. Distribution
C. Metabolism
D. Excretion
Answer: D
Rationale: The kidneys are the primary organs for excretion. Impaired renal function leads
to decreased clearance and potential drug accumulation.
5. A drug that binds to a receptor and activates it to produce a biological
response is known as:
A. An antagonist
B. A placebo
C. An inhibitor
D. An agonist
Answer: D
Rationale: An agonist is a molecule that mimics the action of a naturally occurring
substance by binding to and activating a receptor.
, 6. What does the term ‘therapeutic index’ (TI) represent?
A. The time it takes for a drug to reach peak effect
B. The ratio between a drug’s effective dose and toxic dose
C. The speed at which a drug is absorbed into the blood
D. The duration of a drug’s action
Answer: B
Rationale: The therapeutic index is a measure of drug safety; a narrow TI means the
difference between a therapeutic dose and a toxic dose is small.
7. Which route of administration provides 100% bioavailability?
A. Oral (PO)
B. Intravenous (IV)
C. Sublingual (SL)
D. Subcutaneous (SQ)
Answer: B
Rationale: Intravenous administration injects the drug directly into the systemic
circulation, bypassing absorption barriers and the first-pass effect.
8. What is the half-life of a drug?
A. The time required for the drug to be completely eliminated
B. The time it takes for the concentration of the drug to decrease by 50%
C. The time until the drug starts working
D. The interval between two doses
Answer: B
Rationale: Half-life is the time required for the amount of drug in the body or plasma
concentration to decrease by one-half.
